SEC Form 4 · accession 0001652252-18-000052
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman D Schwartz
Officer — Chairman, President, and CEO · Director · 10% Owner
Period of report
Sep 7, 2018
Accepted (ET)
Sep 11, 2018 · 2:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad B Common StockF1 | Sep 7, 2018 | M | 3,000 | $0.00 | A | 259,145 | D | |
| Bio-Rad B Common Stock | Sep 7, 2018 | F | 1,488 | $313.74 | D | 257,657 | D | |
| Bio-Rad A Common Stock | holding | — | — | — | 412,562 | D | ||
| Bio-Rad B Common StockF2 | holding | — | — | — | 12,717 | I | By Spouse | |
| Bio-Rad B Common StockF3 | holding | — | — | — | 4,060,054 | I | By Blue Raven Partners, L.P. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F5 | $0.00 | Sep 7, 2018 | M | 3,000 | D | — | — | Bio-Rad B Common Stock | 3,000 | 9,000 | D |
Explanation of responses
- F1Shares of Class B common stock acquired on the vesting of restricted stock units.
- F2The reporting person disclaims beneficial ownership of these shares.
- F3The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F4Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.
- F5The restricted stock units vest in five equal annual installments beginning September 7, 2017.